Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Eliska Ceznerova"'
Autor:
Leona Chrastinová, Ondřej Pastva, Markéta Bocková, Hana Kovářová, Eliška Ceznerová, Roman Kotlín, Pavla Pecherková, Jana Štikarová, Alžběta Hlaváčková, Marek Havlíček, Jan Válka, Jiří Homola, Jiří Suttnar
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Aberrant glycosylation of glycoproteins has been linked with various pathologies. Therefore, understanding the relationship between aberrant glycosylation patterns and the onset and progression of the disease is an important research goal th
Externí odkaz:
https://doaj.org/article/dbd5e50cdcae47bb974b43bfdcfaaccf
Autor:
Tomas Simurda, Rui Vilar, Jana Zolkova, Eliska Ceznerova, Zuzana Kolkova, Dusan Loderer, Marguerite Neerman-Arbez, Alessandro Casini, Monika Brunclikova, Ingrid Skornova, Miroslava Dobrotova, Marian Grendar, Jan Stasko, Peter Kubisz
Publikováno v:
Biomedicines, Vol 8, Iss 12, p 605 (2020)
Congenital hypofibrinogenemia is a rare bleeding disorder characterized by a proportional decrease of functional and antigenic fibrinogen levels. Hypofibrinogenemia can be considered the phenotypic expression of heterozygous loss of function mutation
Externí odkaz:
https://doaj.org/article/ba8b9f1b146c40b690bf7f4ed9c97dc4
Autor:
Jan Louzil, Jana Stikarova, Dana Provaznikova, Ingrid Hrachovinova, Tereza Fenclova, Jan Musil, Martin Radek, Jirina Kaufmanova, Vera Geierova, Eliska Ceznerova, Peter Salaj, Roman Kotlin
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 22; Pages: 14386
A single-center study was conducted on 120 patients with inherited disorders of primary hemostasis followed at our hematological center. These patients presented a variety of bleeding symptoms; however, they had no definitive diagnosis. Establishing
Autor:
Alzbeta Hlavackova, Jan Vydra, Leona Chrastinova, Eliska Ceznerova, Marek Havlicek, Jana Stikarova, Roman Kotlin, Jiri Suttnar
Publikováno v:
Blood. 140:11833-11833
Autor:
Eliska Ceznerova, Jirina Kaufmanova, Marek Havlicek, Ondrej Pastva, Alzbeta Hlavackova, Roman Kotlin, Jiri Suttnar
Publikováno v:
Blood. 140:2719-2719
Autor:
Eliska Ceznerova, Miroslava Dobrotova, Dusan Loderer, Monika Brunclikova, Tomas Simurda, Alessandro Casini, Peter Kubisz, Zuzana Kolková, Jana Zolkova, Ingrid Skornova, Jan Stasko, Rui Vilar, Marguerite Neerman-Arbez, Marian Grendar
Publikováno v:
Biomedicines
Biomedicines, Vol 8, Iss 605, p 605 (2020)
Biomedicines, Vol. 8, No 12 (2020) P. 605
Biomedicines, Vol 8, Iss 605, p 605 (2020)
Biomedicines, Vol. 8, No 12 (2020) P. 605
Congenital hypofibrinogenemia is a rare bleeding disorder characterized by a proportional decrease of functional and antigenic fibrinogen levels. Hypofibrinogenemia can be considered the phenotypic expression of heterozygous loss of function mutation
Autor:
Jaromir Novak, Roman Kotlín, Pavla Roselova, Jana Štikarová, Eliska Ceznerova, Martin Hajšl, Pavel Májek, Martin Maly, Jan Louzil, Leona Chrastinova, Ondrej Kucerka, Jan E. Dyr, Jirina Kaufmanova, Alzbeta Hlavackova, Zofie Sovova, Jiri Suttnar
Publikováno v:
Blood. 132:5011-5011
Background Cardiovascular diseases are linked with oxidative stress which is the source of reactive oxidative and nitrative species, contributors of post-translational modification. Fibrinogen due to its high concentration in blood is considered as o
Autor:
Jan Louzil, Eliska Ceznerova, Pavla Roselova, Peter Salaj, Jan E. Dyr, Jiri Suttnar, Jirina Kaufmanova, Jana Štikarová, Roman Kotlín
Publikováno v:
Blood. 132:5046-5046
Fibrinogen is a 340 kDA glycoprotein that plays a vital role in the hemostasis. The three pairs of polypeptide chains (Aα, Bβ and γ) form a heterodimer structure of fibrinogen, each chain is encoded by a distinct gene (FGA, FGB and FGG). Congenita
Autor:
Eliska Ceznerova, Jan E. Dyr, Peter Salaj, Jiri Suttnar, Alzbeta Hlavackova, Ondrej Pastva, Stikarová Jana, Jaroslav Cermak, Roman Kotlín
Publikováno v:
Blood. 126:4697-4697
Introduction Hemostasis in childhood differs from that of adults; and the hemostatic system is still developing during childhood. These differences offer a protective advantage to children with hemorrhagic and thrombotic complications. Plasma levels